Skip to main content
. 2021 Jun 18;10(1):1227–1240. doi: 10.1080/22221751.2021.1937329

Figure 5.

Figure 5.

Inhibitory activity of new lipopeptides against emerging SARS-CoV-2 variants. The inhibitory activities of IPB19-based lipopeptides on the SARS-CoV-2 pseudoviruses bearing the S protein with the emerging mutaions of D614G (A), N501Y (B), Δ69-70 (C), E484K (D), N501Y/Δ69-70/P681H (E), and N501Y/E484K/K417N (F) were determined in Huh-7 cells by the single-cycle infection assay. The experiments were repeated three times, and data are expressed as the means ± SD.